Skip to main content
Premium Trial:

Request an Annual Quote

GenomeQuest, Ingenuity Systems Partner on Workflows for Personalized Medicine

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenomeQuest and Ingenuity Systems today said that they will integrate their respective informatics technologies to support the use of next-generation sequencing tools for personalized medicine research.

The partnership will offer GenomeQuest's Sequence Data Management platform with Ingenuity's IPA software. They said that the combination will enable researchers to "seamlessly exchange gene information, perform interactive analysis, and create and test hypotheses across the domains of genome sequencing and biological pathways."

Westborough, Mass.-based genomeQuest said that the integrated platforms will be available through its RNA-Seq and multi-genome analysis workflows.

"By integrating SDM and IPA, researchers can take NGS experimental results and place them into known and predicted biological contexts that include biological processes, functions, diseases, pathways, compounds, and relationships," Doug Bassett, CSO and CTO of Redwood City, Calif.-based Ingenuity Systems, said in a statement. "This creates a fast and efficient way for researchers to move from a list of genes, isoforms, or variants to high-value discovery outcomes like identifying novel disease-causing variants, prioritizing drug targets, and generating testable hypotheses."

Further terms of the alliance were not disclosed.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.